Over the years, ample research has reported the vital role of SPAG proteins, which may function as promising new biomarkers for diagnosis and prognosis in solid tumorigenesis, yet there is a great lack of systematic investigation of SPAG family member expression and clinical evaluation of these proteins in acute myeloid leukemia (AML) [6]. This evidence concerns the gene RPAP3 and acute myeloid leukemia.